000 01485 a2200445 4500
005 20250518095550.0
264 0 _c20210409
008 202104s 0 0 eng d
022 _a2374-4243
024 7 _a10.1080/23744235.2020.1752395
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetraitiene, Birute
245 0 0 _aPrevalence, clinical expression, invasiveness and outcome of
_h[electronic resource]
260 _bInfectious diseases (London, England)
_c07 2020
300 _a464-472 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aBacterial Toxins
_xblood
650 0 4 _aChild
650 0 4 _aCommunity-Acquired Infections
_xblood
650 0 4 _aEurope
650 0 4 _aExotoxins
_xblood
650 0 4 _aHumans
650 0 4 _aLeukocidins
_xblood
650 0 4 _aLithuania
_xepidemiology
650 0 4 _aMethicillin-Resistant Staphylococcus aureus
650 0 4 _aPrevalence
650 0 4 _aProspective Studies
650 0 4 _aStaphylococcal Infections
_xblood
650 0 4 _aStaphylococcus aureus
700 1 _aConejo, Pablo Rojo
700 1 _aJankauskaite, Lina
700 1 _aKevalas, Rimantas
700 1 _aTrumpulyte, Giedre
700 1 _aSnipaitiene, Ausra
700 1 _aVitkauskiene, Astra
700 1 _aGurskis, Vaidotas
773 0 _tInfectious diseases (London, England)
_gvol. 52
_gno. 7
_gp. 464-472
856 4 0 _uhttps://doi.org/10.1080/23744235.2020.1752395
_zAvailable from publisher's website
999 _c30864456
_d30864456